Yuriko Matsumoto

Molecular Mechanism for Elevation of Asymmetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease

Kyoko Matsuguma, Seiji Ueda, Sho‐ichi Yamagishi et al. · Journal of the American Society of Nephrology · 2006 · 157 citations

Medicine, Biochemistry, Nephrology +14

Dimethylarginine Dimethylaminohydrolase Prevents Progression of Renal Dysfunction by Inhibiting Loss of Peritubular Capillaries and Tubulointerstitial Fibrosis in a Rat Model of Chronic Kidney Disease

Yuriko Matsumoto, Seiji Ueda, Sho‐ichi Yamagishi et al. · Journal of the American Society of Nephrology · 2007 · 106 citations

Medicine, Pathology, Pharmacology +11

Oral Adsorbent AST-120 Decreases Serum Levels of AGEs in Patients with Chronic Renal Failure

Seiji Ueda, Sho‐ichi Yamagishi, Masayoshi Takeuchi et al. · Molecular Medicine · 2006 · 58 citations · Full text

Medicine, Biochemistry, Nephrology +13

Isolation and characterization of major urinary amino acid O-glycosides and a dipeptide O-glycoside from a new lysosomal storage disorder (Kanzaki disease). Excessive excretion of serine- and threonine-linked glycan in the patient urine.

Yoshio Hirabayashi, Yuriko Matsumoto, M Matsumoto et al. · Journal of Biological Chemistry · 1990 · 44 citations · Full text

Life Sciences, Biochemistry, Enzymology +15

Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)

Seiji Ueda, Sho‐ichi Yamagishi, Yuriko Matsumoto et al. · Life Sciences · 2009 · 37 citations

Medicine, Nephrology, Pathobiology +13